Select Publications
Journal articles
2021, 'Care to Quit: a stepped wedge cluster randomised controlled trial to implement best practice smoking cessation care in cancer centres', Implementation Science, 16, pp. 23, http://dx.doi.org/10.1186/s13012-021-01092-5
,2021, 'Variations in lung cancer care and outcomes: How best to identify and improve standards of care?', Respirology, 26, pp. 1103 - 1105, http://dx.doi.org/10.1111/resp.14155
,2021, 'Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review', Frontiers in Oncology, 11, http://dx.doi.org/10.3389/fonc.2021.701424
,2021, 'Increasing Transparency in Author Contributions to Manuscripts: Enhanced Policy on Ghost and Honorary Authorships', Journal of Thoracic Oncology, 16, pp. 706 - 708, http://dx.doi.org/10.1016/j.jtho.2021.03.005
,2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963
,2021, 'OA19.01 Prospective Study of Lung Cancer Screening Criteria: USPSTF2013 vs PLCOm2012 – International Lung Screening Trial (ILST) Results', Journal of Thoracic Oncology, 16, pp. S881 - S881, http://dx.doi.org/10.1016/j.jtho.2021.08.097
,2021, 'P41.07 Lung Cancer Screening: What is the State of the Evidence about Implementation?', Journal of Thoracic Oncology, 16, pp. S475 - S475, http://dx.doi.org/10.1016/j.jtho.2021.01.821
,2021, 'P60.01 Single-Cell Transcriptomics to Assess Response to Immunotherapy in Advanced Lung Cancer ex-vivo: Developing a Functional Predictive Assay', Journal of Thoracic Oncology, 16, pp. S540 - S541, http://dx.doi.org/10.1016/j.jtho.2021.01.960
,2020, 'Essential update in lung cancer medicine', Respirology, 25, pp. 3 - 4, http://dx.doi.org/10.1111/resp.13968
,2020, 'Medicolegal Considerations in Multidisciplinary Cancer Care', JTO Clinical and Research Reports, 1, http://dx.doi.org/10.1016/j.jtocrr.2020.100073
,2020, 'Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand*', Respirology, 25, pp. 1082 - 1089, http://dx.doi.org/10.1111/resp.13904
,2020, 'Multidisciplinary team care in lung cancer', Translational Lung Cancer Research, 9, pp. 1625 - 1628, http://dx.doi.org/10.21037/tlcr-2020-lcmc-08
,2020, 'Optimizing lung cancer MDT data for maximum clinical impact-a scoping literature review', Translational Lung Cancer Research, 9, pp. 1629 - 1638, http://dx.doi.org/10.21037/tlcr.2020.01.02
,2020, 'Molecular testing of metastatic non-small cell lung cancer in the Asia-Pacific region', Respirology, 25, pp. 685 - 687, http://dx.doi.org/10.1111/resp.13833
,2020, 'Clinical impact of data feedback at lung cancer multidisciplinary team meetings: A mixed methods study', Asia-Pacific Journal of Clinical Oncology, 16, pp. 45 - 55, http://dx.doi.org/10.1111/ajco.13278
,2020, 'Protocol and rationale for the international lung screening trial', Annals of the American Thoracic Society, 17, pp. 503 - 512, http://dx.doi.org/10.1513/AnnalsATS.201902-102OC
,2019, 'Oligometastatic Disease in NSCLC — Not Just Wishful Thinking?', Journal of Thoracic Oncology, 14, pp. 2042 - 2045, http://dx.doi.org/10.1016/j.jtho.2019.10.008
,2019, 'Lung Cancer Screenee Selection by USPSTF Versus PLCOm2012 Criteria - Interim ILST Findings', JOURNAL OF THORACIC ONCOLOGY, 14, pp. S4 - S5, http://dx.doi.org/10.1016/j.jtho.2019.08.055
,2019, 'Patterns of care for stage III non–small cell lung cancer in Australia', Asia-Pacific Journal of Clinical Oncology, 15, pp. 93 - 100, http://dx.doi.org/10.1111/ajco.13140
,2019, 'Electronic cigarettes in physician practice: a complex debate', Internal Medicine Journal, 49, pp. 438 - 445, http://dx.doi.org/10.1111/imj.14256
,2019, 'Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer', Oncogene, 38, pp. 1661 - 1675, http://dx.doi.org/10.1038/s41388-018-0536-1
,2019, 'Tobacco and electronic nicotine delivery systems regulation', Translational Lung Cancer Research, 8, pp. S67 - S76, http://dx.doi.org/10.21037/tlcr.2019.03.13
,2019, 'ES13.03 Foundation for a Smoke Free Future: Funding Opportunities or Smoke Screen for the Tobacco Industry?', Journal of Thoracic Oncology, 14, pp. S47 - S47, http://dx.doi.org/10.1016/j.jtho.2019.08.128
,2018, 'Consensus minimum data set for lung cancer multidisciplinary teams: Results of a Delphi process', Respirology, 23, pp. 927 - 934, http://dx.doi.org/10.1111/resp.13307
,2018, 'Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study', Lung Cancer, 124, pp. 199 - 204, http://dx.doi.org/10.1016/j.lungcan.2018.07.032
,2018, 'Prospective Evaluation of the Clinical Utility of the International Lung Screen Trial Lung Nodule Management Protocol', JOURNAL OF THORACIC ONCOLOGY, 13, pp. S362 - S363, http://dx.doi.org/10.1016/j.jtho.2018.08.332
,2018, 'Tobacco cessation in lung cancer screening-do we have the evidence?', Translational Lung Cancer Research, 7, pp. S270 - S274, http://dx.doi.org/10.21037/tlcr.2018.09.09
,2018, '“Teachable Moment” Interventions in Lung Cancer: Why Action Matters', Journal of Thoracic Oncology, 13, pp. 603 - 605, http://dx.doi.org/10.1016/j.jtho.2018.02.020
,2018, 'Cannabis Use, Lung Cancer, and Related Issues', Journal of Thoracic Oncology, 13, pp. 480 - 487, http://dx.doi.org/10.1016/j.jtho.2017.12.013
,2018, 'Tobacco-Free Investment: Harnessing the Power of the Finance Industry in Comprehensive Tobacco Control', QUT Law Review, 17, pp. 161 - 161, http://dx.doi.org/10.5204/qutlr.v17i2.699
,2018, 'Evidence-practice gaps in lung cancer: A scoping review', European Journal of Cancer Care, 27, http://dx.doi.org/10.1111/ecc.12588
,2018, 'The Influence of Histologic Subtype in Predicting Survival of Lung Cancer Patients with Spinal Metastases', Clinical Spine Surgery, 31, pp. E1 - E7, http://dx.doi.org/10.1097/BSD.0000000000000475
,2018, 'Acute Pulmonary Embolism: An update on management', Cardiology Today, 8, pp. 62 - 68
,2017, 'Young low and middle-income country (LMIC) smokers- implications for global tobacco control', Translational Lung Cancer Research, 6, pp. S44 - S46, http://dx.doi.org/10.21037/tlcr.2017.10.11
,2017, 'A randomized phase II trial of CRLX101 in combination with bevacizumab versus standard of care in patients with advanced renal cell carcinoma', Annals of Oncology, 28, pp. 2754 - 2760, http://dx.doi.org/10.1093/annonc/mdx493
,2017, 'Scientific Advances in Thoracic Oncology 2016', Journal of Thoracic Oncology, 12, pp. 1183 - 1209, http://dx.doi.org/10.1016/j.jtho.2017.05.019
,2017, 'The Obesity Paradox—What Does It Mean for Lung Cancer Surgery?', Journal of Thoracic Oncology, 12, pp. 1174 - 1176, http://dx.doi.org/10.1016/j.jtho.2017.06.011
,2017, 'Pathways to lung cancer diagnosis: A Qualitative study of patients and general practitioners about diagnostic and pretreatment intervals', Annals of the American Thoracic Society, 14, pp. 742 - 753, http://dx.doi.org/10.1513/AnnalsATS.201610-817OC
,2017, 'Closing evidence-practice gaps in lung cancer: Results from multi-methods priority setting in the clinical context', Asia-Pacific Journal of Clinical Oncology, 13, pp. 28 - 36, http://dx.doi.org/10.1111/ajco.12499
,2017, 'P1.04-003 The International Lung Screen Trial: A Multi-Center Study to Evaluate LDCT Screening Selection Criteria and Nodule Management', Journal of Thoracic Oncology, 12, pp. S1973 - S1973, http://dx.doi.org/10.1016/j.jtho.2017.09.862
,2017, 'P3.07-019 AMDAT Lung, An Ideal Lung Cancer MDT Dataset', Journal of Thoracic Oncology, 12, pp. S1442 - S1442, http://dx.doi.org/10.1016/j.jtho.2016.11.2210
,2016, 'Tobacco Control and Tobacco Cessation in Lung Cancer - Too Little, Too Late?', Seminars in Respiratory and Critical Care Medicine, 37, pp. 649 - 658, http://dx.doi.org/10.1055/s-0036-1592115
,2016, 'Slowing the Titanic: China's Epic Struggle with Tobacco', Journal of Thoracic Oncology, 11, pp. 2053 - 2065, http://dx.doi.org/10.1016/j.jtho.2016.07.020
,2015, 'Improving Pathways to Early Lung Cancer Diagnosis: Process Mapping and Qualitative Analysis', JOURNAL OF THORACIC ONCOLOGY, 10, pp. S398 - S398, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370365101412&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Patient Advocates in the Lung Cancer Diagnostic Pathway: A Qualitative Study of Interviews with Lung Cancer Patients and Their Caregivers', JOURNAL OF THORACIC ONCOLOGY, 10, pp. S226 - S226, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000370365100365&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Monoclonal precursor T-cell infiltrate in recurrent thymoma: a case report', Pathology, 47, pp. 375 - 377, http://dx.doi.org/10.1097/PAT.0000000000000257
,2015, '500P Dependence of fluorodeoxyglucose avidity on tumour size in non-small cell lung cancer', Annals of Oncology, 26, pp. ix153 - ix153, http://dx.doi.org/10.1093/annonc/mdv534.04
,2014, 'Pulmonary artery stent for bronchial adenoid cystic carcinoma causing pulmonary artery stenosis', Respirology Case Reports, 2, pp. 39 - 41, http://dx.doi.org/10.1002/rcr2.42
,2014, 'High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer', Internal Medicine Journal, 44, pp. 1188 - 1192, http://dx.doi.org/10.1111/imj.12587
,2013, 'IDENTIFYING EVIDENCE-PRACTICE GAPS IN LUNG CANCER AND PRIORITY SETTING WITH CLINICIANS IN NSW, AUSTRALIA', JOURNAL OF THORACIC ONCOLOGY, 8, pp. S699 - S700, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,